New chemotherapies for ovarian cancer. Systemic and intraperitoneal podophyllotoxins
β Scribed by Franco M. Muggia; Christy A. Russell
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 558 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Five to ten percent of patients with adenocarcinoma of the endometrium present with advanced disease [1] or develop metastasis and require systemic therapy for control of disease. About oneβthird (33%) of recurrent or advanced endometrial cancer responds to progestational agents [2β4].
Between 1973 and 1985, 118 patients in clinical remission after initial surgery and postoperative chemotherapy for epithelial ovarian carcinoma underwent second-look laparotomy at the University of North CaroIim. No evidence of disease (NED) was found in 57 of these patients; 43 patients received 15